<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365088">
  <stage>Registered</stage>
  <submitdate>2/10/2013</submitdate>
  <approvaldate>4/10/2013</approvaldate>
  <actrnumber>ACTRN12613001116718</actrnumber>
  <trial_identification>
    <studytitle>Free lymph node transfer in the treatment of lymphoedema</studytitle>
    <scientifictitle>In patients with upper limb lymphoedema, does free lymph node transfer from the groin, compared to conservative management, improve the limb circumference?</scientifictitle>
    <utrn>U1111-1146-4617</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>lymphoedema</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Free transfer of lymph nodes from groin to upper limb.  This involves an incision in the groin with removal of up to 4 nodes under local anaesthetic.  They will then be transplanted to the elbow or wrist of the affected limb.  We estimate the duration of the procedure to be approx 60 mins.</interventions>
    <comparator>Conservative/standard lymphoedema care - this includes massage, bandaging and limb positioning as directed/provided by lymphoedema nurses and physiotherapists.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Reduction in limb circumference - this is measured by circumferential measurements of the limb at the ulnar styloid and 2 cm proximal to the elbow.</outcome>
      <timepoint>6 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Quantify the change in limb circumference following this procedure - this is measured by circumferential measurements of the limb at the ulnar styloid and 2 cm proximal to the elbow.  And compared to measurements prior to the procedure to create a percentage reduction.</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Complication rates associated with the procedure - developing lymphoedema in the donor limb; necrotic lymph node grafts; infection; poor cosmesis.
All of these would be assessed by clinical examination at each follow up appointment.</outcome>
      <timepoint>6 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>stable lymphoedema in an upper limb, no further surgery required on that limb</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>smoking, BMI &gt; 30, poorly controlled diabetes, comorbidities that could cause limb oedema eg. CHF, cirrhosis, low albumin</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods>Pilot study to assess initial efficacy of technique.  </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/10/2013</anticipatedstartdate>
    <actualstartdate>10/10/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>5/06/2014</actualenddate>
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Waikato DHB</primarysponsorname>
    <primarysponsoraddress>c/o Waikato Hospital
Pembroke St
Hamilton 3201
</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Waikato DHB</fundingname>
      <fundingaddress>c/o Waikato Hospital
Pembroke St
Hamilton 3201
</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>An interventional study to assess the viability of free lymph node transfer in the	 treatment of upper	limb lymphoedema following axillary clearance.				
Our study	hypothesises that lymph nodes act to move lymphatic	fluid from	the soft tissues into	lymphatic vessels through the pump effect.		
The study hypothesises that vascular supply by diffusion is sufficient to facilitate this, and that microvascular transfer is not required for a reduction in	lymphoedema.</summary>
    <trialwebsite />
    <publication>Currently submitted and being considered by ANZ Journal of Surgery for publication</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central HDEC</ethicname>
      <ethicaddress />
      <ethicapprovaldate>1/10/2013</ethicapprovaldate>
      <hrec>13/CEN/117</hrec>
      <ethicsubmitdate>14/08/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Winston McEwan</name>
      <address>c/o Waikato Hospital
Pembroke St
Hamilton 3201
</address>
      <phone>+64 7 839 8899</phone>
      <fax />
      <email>Winston.McEwan@waikatodhb.health.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Elizabeth Travis</name>
      <address>c/o RMO Unit
Waikato Hospital
Pembroke St
Hamilton 3201</address>
      <phone>+64 7 839 8899</phone>
      <fax />
      <email>Elizabeth.Travis@waikatodhb.health.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Elizabeth Travis </name>
      <address>c/o RMO Unit
Waikato Hospital
Pembroke St
Hamilton 3201</address>
      <phone>+64 7 839 8899</phone>
      <fax />
      <email>Elizabeth.Travis@waikatodhb.health.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>